Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) · 2025
International consensuses and guidelines on etiology, diagnosis, treatment, and future developments of neovascular age-related macular degeneration (nAMD) by the Asia-Pacific Vitreo-retina Society (APVRS), the Asia-Pacific Ocular Imaging Society (APOIS) and the Academy of the Asia-Pacific Professors of Ophthalmology (AAPPO).
СтатьяОбзорConsensus StatementНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lai Timothy Y Y, Kataoka Keiko, Hsieh Yi-Ting, Apte Rajendra S, Bhende Muna, Chang Andrew, Chiakitmongkol Voraporn, Chen Youxin, Chen Li Jia, Cheung Gemmy C M, Chhablani Jay, Fong Kenneth C S, Guymer Robyn H, Gomi Fumi, Huang Suber S, Kim Judy E, Kokame Gregg T, Koh Adrian, Li Xiaoxin, Lim Jennifer I, Ng Danny S C, Okada Annabelle A, Radke Nishant V, Sadda Srinivas R, Sasaki Mariko, Sivaprasad Sobha, Shanmugam Mahesh P, Verma Lalit, Wong Tien-Yin, Zhang Xinyuan, Lam Dennis S C
Аннотация
Neovascular age-related degeneration (nAMD) is one of the leading causes of visual impairment in older populations in the developed world. With the aging population, the incidence of nAMD is growing globally. Despite advancements in diagnostic investigations and treatment modalities over the past three decades, there remains considerable controversies in the pathogenesis, classification and optimal management strategies. An international panel of 31 experts from 11 countries/regions prepared and voted on consensus statements in five key areas: (1) etiology controversies; (2) diagnosis controversies; (3) treatment controversies; (4) future development controversies; and (5) healthcare deliveries controversies. Among the 31 consensus statements, 28 (90.3 %) have achieved over 75 % agreement. These statements can provide a practical guide for ophthalmologists to provide the optimal care of patients with nAMD and for planning future research priorities in order to address the unmet needs in nAMD.